Canopy Growth (TSX: WEED) (Nasdaq: CGC) has launched Spectrum Reserve, a new premium medical cannabis brand in Canada through its medical division Spectrum Therapeutics. The brand focuses on premium genetics selected for size, potency, and terpene levels.
The program will introduce new strains regularly based on patient feedback, with successful strains remaining in market while others are phased out. The initial release includes four flower strains:
- Power Plant x Super Silver Haze (Indica, 22-25% THC, 2.21% terpenes)
- Grape Star x Golden Lemons (Sativa, 22-25% THC, 1.77% terpenes)
- Malawi x Kosher Tangie (Hybrid, 27-30% THC, 2.59% terpenes)
- Raspberry Parfait (Sativa-Dominant Hybrid, 22-27% THC, 2.59% terpenes)
Canopy Growth (TSX: WEED) (Nasdaq: CGC) ha lanciato Spectrum Reserve, un nuovo marchio premium di cannabis medica in Canada attraverso la sua divisione…
